New-onset diabetes after kidney transplantation: Incidence and associated factors

Table 1 Clinical and laboratory parameters

	NODAT group	Non-NODAT group	P
No. of patients	34 (27.2%)	91 (72.8%)
Age at transplant (yr)	49.6 ± 10.8	46.0 ± 13.6	0.165
Female sex	53% (18/34)	47% (43/91)	0.571
Race Caucasian African	70.6% (24/34) 29.4% (10/34)	78% (71/91) 22% (20/91)	0.387
Body mass index (kg/m2)	25.2 ± 4.0	24.5 ± 4.4	0.418
Pre-transplant FPG (mg/dL)	101 (96.1-105.7)	92 (91.4-95.8)	0.007
Pretransplant IFG	51.5% (17/33)	27.7% (23/83)	0.01
Hepatitis C infection	2.9% (1/34)	1.1% (1/91)	0.472
CMV infection	97% (33/34)	93% (82/88)	0.672
Acute rejection	14.7% (5/34)	8.8% (8/91)	0.338
Type of transplant Deceased donor Living donor	100% (34/34) 0% (0/34)	91.2% (83/91) 8.8 % (8/91)	0.106
Follow-up (mo)	36.4 ± 2.5	35.5 ± 1.6	0.774

CMV: Cytomegalovirus; FPG: Fasting plasma glucose; IFG: Impaired fasting glucose; NODAT: New-onset diabetes after transplantation.